Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients

Published:2015-04 Issue: Volume:58 Page:48-58
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Rosenzwajg Michelle,Churlaud Guillaume,Mallone Roberto,Six Adrien^ORCID,Dérian Nicolas,Chaara Wahiba,Lorenzon Roberta,Long S. Alice,Buckner Jane H.,Afonso Georgia,Pham Hang-Phuong^ORCID,Hartemann Agnès,Yu Aixin,Pugliese Alberto,Malek Thomas R.,Klatzmann David

Funder

DRCD

CIC-PE

CIC-BTi

Inserm

National Institute of Allergy and Infectious Diseases

Juvenile Diabetes Research Foundation

Diabetes Research Institute Foundation

Peacock Foundation, Inc.

Anton E. B. Schefer Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. FOXP3+ regulatory T cells in the human immune system;Sakaguchi;Nat Rev Immunol,2010

2. Natural regulatory T cells control the development of atherosclerosis in mice;Ait-Oufella;Nat Med,2006

3. Phenotypical and functional specialization of FOXP3+ regulatory T cells;Campbell;Nat Rev Immunol,2011

4. Regulatory T cells exert checks and balances on self tolerance and autoimmunity;Wing;Nat Immunol,2010

5. Defective regulatory and effector T cell functions in patients with FOXP3 mutations;Bacchetta;J Clin Invest,2006

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

2. Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial;2024-09-04

3. Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease;Advanced Drug Delivery Reviews;2024-09

4. Reg2 treatment is protective but the induced Reg2 autoantibody is destructive to the islets in NOD mice;Biochemical Pharmacology;2024-09

5. Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial;Brain, Behavior, and Immunity;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3